Matt David, M.D.

CFO

Equibles does not estimate personal net worth.

About Matt David, M.D.

Matt David, M.D. is recorded as CFO at Actinium Pharmaceuticals, Inc. (ATNM) since October 14, 2026. Actinium Pharmaceuticals, Inc. reported in an 8-K filed October 15, 2026 that Matt David, M.D. was appointed Chief Financial Officer and principal financial officer, effective October 14, 2026. Actinium Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Actinium Pharmaceuticals, Inc. includes Sandesh Seth (CEO and Board Member), Matt David (CFO), Ajit S. Shetty (Board Member) and 5 others.

“On October 14, 2026, Matt David, M.D., age 49, commenced service as Chief Financial Officer and principal financial officer of Actinium Pharmaceuticals, Inc. (the “Company”).”

Actinium Pharmaceuticals, Inc. Form 8-K, filed October 15, 2026 · Read the filing

Affiliation history

Actinium Pharmaceuticals, Inc. (ATNM)
CFO

SEC 8-K

Current
2026-10-14–present

Company network

Actinium Pharmaceuticals, Inc.

ATNM

Current role

Biotechnology · Healthcare

CFO

2026-10-14–present

Leadership on record at Actinium Pharmaceuticals, Inc.

Sandesh Seth CEO, Board Member
Matt David CFO
Ajit S. Shetty Board Member
David Nicholson Board Member
Jeffrey W. Chell Board Member
June Almenoff, M.D., Ph.D. Board Member
June S. Almenoff Board Member
Richard I. Steinhart Board Member

Recent activity

Executive change Appointed: Chief Financial Officer and principal financial officer Actinium Pharmaceuticals, Inc. (ATNM)
2026-10-14